```html

Out‑of‑Hospital Cardiac Arrest (OHCA): A Patient‑Friendly Guide

Overview

Out‑of‑hospital cardiac arrest (OHCA) occurs when the heart suddenly stops beating effectively **outside of a medical facility**. When the heart can no longer pump blood, oxygen delivery to the brain and other vital organs ceases within seconds, leading to loss of consciousness and, if untreated, death.

• Who it affects: OHCA can happen to anyone, but incidence rises sharply with age and is higher in men than women (roughly 3:1 in many registries). 
• Prevalence: In the United States, about 350,000 adults experience out‑of‑hospital cardiac arrest each year; only 10‑12 % survive to hospital discharge. Similar rates are reported across Europe and Asia, with overall survival ranging from 5‑15 % depending on the region’s emergency‑response system (CDC, 2021; WHO, 2022).
• Why it matters: Immediate by‑stander cardiopulmonary resuscitation (CPR) and rapid defibrillation are the strongest predictors of survival, yet fewer than 40 % of arrests receive by‑stander CPR worldwide.

Symptoms

Because cardiac arrest is a sudden loss of circulation, the “symptoms” are actually the **clinical signs** observed by witnesses or rescuers. They differ from the warning signs of a heart attack, which can precede an arrest.

Classic signs of cardiac arrest

• Sudden collapse – The person falls unconscious without any warning.
• No pulse – No detectable carotid or radial pulse.
• No breathing or abnormal “gasping” (agonal respirations) – Breathing may appear irregular, weak, or absent.
• Unresponsive to voice or touch – The person cannot be roused.
• Chest discomfort before collapse (in some cases) – May be a brief, intense pressure or heaviness that precedes the arrest.
• Seizure‑like activity – Occasionally, the brain’s lack of oxygen triggers jerky movements that can be mistaken for a seizure.

Warning signs that can precede an arrest

While not symptoms of the arrest itself, recognizing these prodromal clues can prompt early medical evaluation and possibly prevent OHCA.

• Chest pain or pressure lasting > 5 minutes
• Shortness of breath at rest or with minimal exertion
• Palpitations or a feeling of “fluttering” in the chest
• Dizziness, light‑headedness, or syncope (fainting)
• Sudden severe weakness, especially on one side of the body

Causes and Risk Factors

Primary cardiac causes (≈ 80 % of cases)

• Ventricular fibrillation (VF) or ventricular tachycardia (VT) – Disorganized electrical activity that prevents effective pumping.
• Acute myocardial infarction (heart attack) – Blocked coronary artery leading to tissue death and electrical instability.
• Coronary artery disease (CAD) – Chronic plaque buildup that predisposes to VF/VT.
• Structural heart disease – Hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy.
• Congenital heart defects – Especially those affecting the conduction system.

Non‑cardiac causes (≈ 20 % of cases)

• Severe electrolyte abnormalities (e.g., hyper‑ or hypokalemia)
• Respiratory failure or severe hypoxia (e.g., drowning, choking)
• Major trauma (blunt or penetrating)
• Drug overdose or poisoning (especially opioids, cocaine, or anti‑arrhythmics)
• Massive pulmonary embolism
• Severe bleeding or hypovolemia

Risk factors

• Age > 65 years (risk doubles each decade after 45)
• Male sex
• History of coronary artery disease, prior myocardial infarction, or heart failure
• Known ventricular arrhythmias or previous cardiac arrest
• Family history of sudden cardiac death
• Smoking, hypertension, diabetes mellitus, dyslipidemia
• Obesity (BMI ≥ 30 kg/m²)
• Physical inactivity
• Substance abuse (cocaine, methamphetamine, excessive alcohol)
• Genetic channelopathies (e.g., Long QT syndrome, Brugada syndrome)

Diagnosis

Because OHCA is an emergency, the **primary diagnosis** is made in the field by emergency medical services (EMS) personnel.

Field assessment

• Check responsiveness, breathing, and pulse.
• Apply an automated external defibrillator (AED) – the device analyzes rhythm and delivers a shock if VF/VT is present.
• Document the time of collapse, by‑stander CPR, and first shock.

Hospital evaluation (after ROSC – return of spontaneous circulation)

1. 12‑lead Electrocardiogram (ECG) – To identify ST‑segment changes, Q‑waves, or other arrhythmias.
2. Cardiac biomarkers (troponin I/T) – Elevated levels suggest myocardial infarction.
3. Echocardiography – Assesses ventricular function, wall motion abnormalities, structural defects.
4. Coronary angiography – Indicated when a myocardial infarction is suspected; allows for immediate revascularization.
5. Laboratory tests – Electrolytes, arterial blood gases, glucose, coagulation profile.
6. Neurologic assessment – Glasgow Coma Scale, brain imaging (CT/MRI) if head injury is suspected.
7. Genetic testing (in selected survivors) – For inherited channelopathies when family history is suggestive.

Treatment Options

Treatment is divided into **immediate out‑of‑hospital care** and **post‑resuscitation hospital care**.

Immediate (pre‑hospital) care

• High‑quality by‑stander CPR – Chest compressions at 100‑120/min, depth 5‑6 cm, allowing full recoil.
• AED use – Provides defibrillation within 3‑5 minutes of collapse; each minute of delay reduces survival by ~10 % (AHA, 2020).
• Advanced life support (ALS) – EMS administers epinephrine 1 mg IV/IO every 3‑5 minutes, consider amiodarone for refractory VF/VT.
• Airway management – Bag‑valve‑mask ventilation or endotracheal intubation as skill permits.

Hospital‑based care after ROSC

• Targeted temperature management (TTM) – Cooling to 32‑36 °C for 24 hours improves neurologic outcome (NIH, 2021).
• Coronary reperfusion – Primary percutaneous coronary intervention (PCI) within 90 minutes for suspected cardiac cause.
• Mechanical circulatory support – Extracorporeal membrane oxygenation (ECMO) or intra‑aortic balloon pump in selected patients.
• Anti‑arrhythmic therapy – Amiodarone, lidocaine, or beta‑blockers based on rhythm.
• Optimization of underlying disease – Revascularization, valve repair, or management of heart failure.

Long‑term secondary prevention

• Implantable cardioverter‑defibrillator (ICD) – Recommended for survivors of ventricular fibrillation or those with low ejection fraction (<35 %).
• Beta‑blockers, ACE inhibitors/ARBs, statins – Standard post‑MI and heart‑failure therapy.
• Antiplatelet agents (aspirin + P2Y12 inhibitor) after PCI.
• Lifestyle modification (see Prevention section).

Living with Out‑of‑Hospital Cardiac Arrest

Surviving an OH CA can be life‑changing. Below are practical steps to help patients and families adjust.

Physical recovery

• Cardiac rehabilitation – Structured, supervised exercise 3‑5 times/week for 12‑24 weeks (Cleveland Clinic, 2022).
• Gradual return to daily activities – Start with light walking, avoid heavy lifting for 4‑6 weeks unless cleared.
• Monitor for post‑cardiac arrest syndrome – Fatigue, depression, cognitive difficulties.

Medication adherence

• Use a pill organizer or daily alarm.
• Keep a medication list and share it with every health‑care provider.

Psychosocial support

• Counseling or support groups for survivors and families.
• Screen for anxiety, depression, or post‑traumatic stress disorder (PTSD) at follow‑up visits.

Emergency preparedness

• Wear a medical alert bracelet stating “History of cardiac arrest – needs immediate defibrillation.”
• Ensure home has an AED if feasible; otherwise, know the nearest public AED locations.
• Teach close relatives high‑quality CPR and how to use an AED.

Prevention

While not all arrests can be prevented, many strategies markedly reduce risk.

• Control cardiovascular risk factors:
  • Blood pressure < 130/80 mmHg (American Heart Association target).
  • LDL cholesterol < 70 mg/dL for high‑risk patients.
  • HbA1c < 7 % for diabetics.
• Smoking cessation – Use nicotine replacement, counseling, or prescription medications (e.g., varenicline).
• Regular aerobic exercise – At least 150 minutes of moderate‑intensity activity weekly.
• Weight management – Aim for BMI 18.5‑24.9 kg/m².
• Limit alcohol – No more than 2 drinks/day for men, 1 for women.
• Screening for hereditary arrhythmias – Family history of sudden death warrants ECG and possibly genetic testing.
• Medication review – Avoid QT‑prolonging drugs unless essential; discuss any changes with a clinician.
• Public health measures – Community CPR training, widespread AED deployment, and “hands‑only” CPR campaigns improve survival (CDC, 2021).

Complications

If an out‑of‑hospital cardiac arrest is not promptly treated, or even after successful resuscitation, several complications may arise.

• Neurologic injury – Anoxic brain injury can lead to cognitive deficits, seizures, or persistent vegetative state.
• Myocardial dysfunction – “Stunned” heart muscle may cause low cardiac output and pulmonary edema.
• Acute kidney injury – Due to hypoperfusion.
• Coagulopathy & bleeding – From systemic inflammatory response.
• Multi‑organ failure – In severe cases, leading to prolonged intensive care stays.
• Psychological sequelae – PTSD, depression, and anxiety are common in survivors and families.

When to Seek Emergency Care

References

1. American Heart Association. 2020 Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. AHA, 2020.
2. Centers for Disease Control and Prevention. Sudden Cardiac Arrest in the United States. CDC, 2021.
3. World Health Organization. Global Cardiovascular Disease Atlas. WHO, 2022.
4. Mayo Clinic. “Cardiac Arrest.” Accessed May 2026.
5. Cleveland Clinic. “Cardiac Rehabilitation: What to Expect.” 2022.
6. National Institutes of Health. “Targeted Temperature Management After Cardiac Arrest.” 2021.
7. European Resuscitation Council. “ERC Guidelines for Resuscitation 2023.”

```